Avaleht › Interstitsiaalsed kopsuhaigused › Texas
Interstitsiaalsed kopsuhaigused kliinilised uuringud osariigis Texas
18 uuringut haiguse Interstitsiaalsed kopsuhaigused jaoks otsivad osalejaid osariigis Texas.
Linnad osariigis Texas
Ametlik uuringutekst (inglise keeles)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- Baylor University Medical Center, Dallas
- Metroplex Pulmonary & Sleep Center, McKinney
- UT Health San Antonio, San Antonio
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 1. okt 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- Baylor College of Medicine, Houston
VärbamineFaas 3
Vanused 40 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Stryde Research, Carrollton
- Baylor University Medical Center, Dallas
- Discovery Clinical Trials, San Antonio
- ja veel 1
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 29. sept 2026 · NCT05798923A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Houston
- GSK Investigational Site, Temple
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT06572384A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Denison
- GSK Investigational Site, El Paso
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 8. sept 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- El Paso Pulmonary Association, El Paso
- Baylor College of Medicine, Houston
- Baylor Scott and White Health, Temple
VärbamineFaas 2
Vanused 40 ja vanemad · Kõik sood · Uuendatud 4. sept 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- Baylor University Medical Center, Dallas
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Värbamine
Vanused 18 ja vanemad · Kõik sood · Uuendatud 2. sept 2026 · NCT06911632A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Houston
VärbamineFaas 2
Vanused 18–85 · Kõik sood · Uuendatud 2. sept 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Baylor University Medical Center, Dallas
- UT Southwest Medical Center Heart and Lung Clinic, Dallas
- Houston Methodist, Houston
- ja veel 1
VärbamineVaatlusuuring
Vanused 18 ja vanemad · Kõik sood · Uuendatud 26. aug 2026 · NCT06388421PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
- University of Texas Southwestern, Dallas
VärbamineVaatlusuuring
Vanused 18–80 · Kõik sood · Uuendatud 18. aug 2026 · NCT06855329Platform Clinical Study for Conquering Scleroderma
- University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics, Houston
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 18. aug 2026 · NCT06195072Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Texas Southwestern, Dallas
- Baylor University Medical Center at Dallas, Dallas
- Baylor College of Medicine, Houston
- ja veel 2
VärbamineVaatlusuuring
Vanused 21 ja vanemad · Kõik sood · Uuendatud 12. aug 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Houston Methodist Hospital, Houston
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 10. aug 2026 · NCT07175038Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Baylor University Medical Center, Dallas
- UT Southwestern Medical Center-Advanced Lung Clinic, Dallas
- Houston Methodist Outpatient Center, Houston
- ja veel 4
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 13. juuli 2026 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Baylor College of Medicine/Texas Children'S Hospital, Houston
VärbamineVaatlusuuring
Kuni 24 aastane · Kõik sood · Uuendatud 22. juuni 2026 · NCT04098445A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site#7096, Arlington
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 31. märts 2026 · NCT07047690Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- University of Texas Southwestern Medical Center, Dallas
- Metroplex Pulmonary and Sleep Center, McKinney
- Research Centers of America, McKinney
VärbamineFaas 2
Vanused 40 ja vanemad · Kõik sood · Uuendatud 12. nov 2025 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Dallas
- aTyr Investigative Site, Houston
VärbamineFaas 2
Vanused 18 ja vanemad · Kõik sood · Uuendatud 7. mai 2025 · NCT05892614Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.